These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

675 related items for PubMed ID: 19036425

  • 1. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial.
    Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK.
    Lancet; 2008 Dec 20; 372(9656):2115-23. PubMed ID: 19036425
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.
    Tfelt-Hansen P.
    Headache; 2011 Jan 20; 51(1):118-23. PubMed ID: 21070229
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
    Lynch JJ, Regan CP, Edvinsson L, Hargreaves RJ, Kane SA.
    J Cardiovasc Pharmacol; 2010 May 20; 55(5):518-21. PubMed ID: 20164785
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CGRP-receptor antagonism in migraine treatment.
    Edvinsson L.
    Lancet; 2008 Dec 20; 372(9656):2089-90. PubMed ID: 19036426
    [No Abstract] [Full Text] [Related]

  • 10. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention.
    Ho TW, Connor KM, Zhang Y, Pearlman E, Koppenhaver J, Fan X, Lines C, Edvinsson L, Goadsby PJ, Michelson D.
    Neurology; 2014 Sep 09; 83(11):958-66. PubMed ID: 25107879
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Randomized, controlled study of telcagepant in patients with migraine and coronary artery disease.
    Ho TW, Ho AP, Chaitman BR, Johnson C, Mathew NT, Kost J, Fan X, Aurora SK, Brandes JL, Fei K, Beebe L, Lines C, Krucoff MW.
    Headache; 2012 Feb 09; 52(2):224-35. PubMed ID: 22221076
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J.
    Headache; 2006 Jan 09; 46(1):101-9. PubMed ID: 16412157
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.